Trials / Recruiting
RecruitingNCT07507474
Performance of the Treatment of Periodontitis According to the Bioperio® Protocol
Performance of the Treatment of Periodontitis According to the Bioperio® Protocol: a Prospective Cohort Study
- Status
- Recruiting
- Phase
- —
- Study type
- Observational
- Enrollment
- 600 (estimated)
- Sponsor
- University of Pisa · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This multicenter, prospective, single-arm observational study evaluated the 3-month clinical performance of the Bioperio® protocol, a standardized, patient-centered framework for managing periodontitis. The protocol combined professional supra-gingival scaling, oral hygiene instruction and motivation, full-mouth subgingival instrumentation, and-in Stage III/IV cases-adjunctive enamel matrix derivative application in deep pockets.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIAGNOSTIC_TEST | periodontal probing and charting | All clinical periodontal parameters were assessed at baseline and at the 3-month follow-up by calibrated examiners. Probing Instrument: A manual periodontal probe (UNC 15, Hu-Friedy, Chicago, IL, USA) was used. Examiners were calibrated to apply a consistent probing force of 0.25 N using a force-measuring scale. Measurements: For each tooth, six sites were examined: mesiobuccal, mid-buccal, distobuccal, mesiolingual, mid-lingual, and distolingual. Probing Pocket Depth (PPD): Measured in millimeters from the gingival margin to the base of the pocket; rounded to the nearest millimeter. Gingival Recession (REC): Measured in millimeters from the cementoenamel junction to the gingival margin; recorded as a positive value when the gingival margin was apical to the cementoenamel junction. Clinical Attachment Level (CAL): Calculated as PPD + REC for each site. Bleeding on Probing (BOP): Recorded dichotomously (present/absent) at the same six sites per tooth. The full-mouth bleeding score |
Timeline
- Start date
- 2023-12-05
- Primary completion
- 2025-07-05
- Completion
- 2030-12-05
- First posted
- 2026-04-02
- Last updated
- 2026-04-08
Locations
1 site across 1 country: Italy
Source: ClinicalTrials.gov record NCT07507474. Inclusion in this directory is not an endorsement.